Q203
≥99%
- Product Code: 102207
CAS:
1334719-95-7
| Molecular Weight: | 557.01 g./mol | Molecular Formula: | C₂₉H₂₈ClF₃N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Q203 is primarily investigated for its potential in treating tuberculosis (TB), particularly drug-resistant strains. It works by inhibiting the cytochrome bc1 complex, a critical component of the bacterial respiratory chain, thereby disrupting energy production in Mycobacterium tuberculosis. This mechanism makes it a promising candidate for inclusion in TB drug regimens, especially in cases where first-line treatments fail. Research is ongoing to evaluate its efficacy, safety, and potential combination with other anti-TB drugs to enhance therapeutic outcomes. Its development represents a significant step forward in addressing the global challenge of multidrug-resistant TB.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98.5-100.0 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $299.01 |
+
-
|
| 0.005 | 10-20 days | $365.46 |
+
-
|
| 0.025 | 10-20 days | $391.62 |
+
-
|
| 0.050 | 10-20 days | $626.26 |
+
-
|
| 0.100 | 10-20 days | $1,001.68 |
+
-
|
Q203
Q203 is primarily investigated for its potential in treating tuberculosis (TB), particularly drug-resistant strains. It works by inhibiting the cytochrome bc1 complex, a critical component of the bacterial respiratory chain, thereby disrupting energy production in Mycobacterium tuberculosis. This mechanism makes it a promising candidate for inclusion in TB drug regimens, especially in cases where first-line treatments fail. Research is ongoing to evaluate its efficacy, safety, and potential combination with other anti-TB drugs to enhance therapeutic outcomes. Its development represents a significant step forward in addressing the global challenge of multidrug-resistant TB.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :